FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation
-
Add time:07/20/2019 Source:sciencedirect.com
AimMyokines are associated with regulation of bone and muscle mass. However, limited information is available regarding the impact of myokines on glucocorticoid (GC) mediated adverse effects on the musculoskeletal system. This study investigates the role of myokine fibroblast growth factor-2 (FGF-2) in regulating GC-induced deleterious effects on bone and skeletal muscle.
We also recommend Trading Suppliers and Manufacturers of Bovine FGF (cas 106096-92-8). Pls Click Website Link as below: cas 106096-92-8 suppliers
Prev:Cloning and analysis of 1-hydroxy-2-methyl-2-(E)-butenyl-4-diphosphate reductase genes HsHDR1 and HsHDR2 in Huperzia serrate
Next:The LIS1/NDE1 Complex Is Essential for FGF Signaling by Regulating FGF Receptor Intracellular Trafficking) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- An efficient large-scale refolding technique for recovering biologically active recombinant human FGF-21 from inclusion bodies07/26/2019
- Hair regenerative effect of silk fibroin hydrogel with incorporation of FGF-2-liposome and its potential mechanism in mice with testosterone-induced alopecia areata07/25/2019
- Effect of FGF-21 on implant bone defects through hepatocyte growth factor (HGF)-mediated PI3K/AKT signaling pathway07/24/2019
- A Sprouty4 reporter to monitor FGF/ERK signaling activity in ESCs and mice07/23/2019
- The LIS1/NDE1 Complex Is Essential for FGF Signaling by Regulating FGF Receptor Intracellular Trafficking07/22/2019
